pyrazolanthrone has been researched along with angiotensin ii in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ingelfinger, JR; Moini, B; Zhang, SL | 1 |
| Chou, MY; Chueh, PJ; Huang, CY; Kuo, WW; Tseng, CT; Yang, JJ | 1 |
| Chen, R; Ding, G; Guan, X; Huang, S; Pan, X; Wu, Y; Yang, T; Zhang, A | 1 |
| Fujii, T; Fukutomi, M; Inoue, R; Kobayashi, H; Kurose, H; Maruyama, Y; Nagamatsu, Y; Nagao, T; Nishida, M; Nishihara, N; Onohara, N; Shibasaki, F; Sumimoto, H; Tanabe, S | 1 |
| Berk, BC; Che, ZQ; Gao, PJ; Ji, KD; Shen, WL; Yan, C; Yin, M; Zhu, DL | 1 |
| González, I; Jiménez, E; Montiel, M; Pérez de la Blanca, E; Salas, J; Urso, L | 1 |
| Bataller, R; Colmenero, J; De Minicis, S; Gwak, GY; Kluwe, J; Mencin, A; Osterreicher, CH; Pradere, JP; Schwabe, RF | 1 |
| Chen, RH; Ding, GX; Huang, SM; Pan, XQ; Zhang, AH | 1 |
| Andersen, DC; Christensen, GL; Eskildsen, T; Gammeltoft, S; Hansen, JL; Jensen, HB; Jeppesen, PL; Nossent, AY; Schneider, M; Sheikh, SP | 1 |
| Dai, QY; Gao, FH; Li, ZZ; Wu, HX; Xu, MD; Yao, HL; Zhang, Z | 1 |
| Chen, C; Du, J; Li, HH; Meng, Y; Tian, C | 1 |
| Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
| Jiang, X; Li, SH; Li, ZH; Liang, JX; Liao, X; Liu, HW; Wu, F; Wu, YD; Xu, Y; Yan, JX | 1 |
| Chiu, CZ; Shyu, KG; Wang, BW; Yu, YJ | 1 |
14 other study(ies) available for pyrazolanthrone and angiotensin ii
| Article | Year |
|---|---|
Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor.
Topics: Angiotensin II; Animals; Anthracenes; Blotting, Western; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Flavonoids; Genistein; Imidazoles; Kidney; Losartan; Mice; Microscopy, Fluorescence; Onium Compounds; PAX2 Transcription Factor; Phosphorylation; Plasmids; Pyridines; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factors; Tyrphostins; Up-Regulation | 2004 |
Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.
Topics: Actins; Angiotensin II; Animals; Anthracenes; Atrial Natriuretic Factor; Cell Size; Cells, Cultured; Humans; Hypertrophy; Interleukins; MAP Kinase Kinase 7; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Phenylephrine; Protein Kinase Inhibitors; Protein Kinases; Rats; Recombinant Fusion Proteins; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2004 |
c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells.
Topics: Angiotensin II; Anthracenes; Cell Division; Cells, Cultured; Enzyme Activation; Glomerular Mesangium; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Transcription, Genetic; Vasoconstrictor Agents | 2005 |
Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts.
Topics: Active Transport, Cell Nucleus; Adenoviridae; Angiotensin II; Animals; Anthracenes; Blotting, Western; Calcium; Cell Nucleus; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Fibroblasts; Genes, Dominant; Green Fluorescent Proteins; GTP-Binding Protein alpha Subunits, G12-G13; Heart Ventricles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Models, Chemical; Myocardium; NADPH Oxidases; NFATC Transcription Factors; Nuclear Proteins; Onium Compounds; Phosphoproteins; Phosphorylation; Plasmids; Protein Binding; Protein Structure, Tertiary; Protein Transport; rac GTP-Binding Proteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Angiotensin; Signal Transduction; Time Factors; Transcription Factors; Transcriptional Activation | 2005 |
NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anthracenes; Aorta, Thoracic; Cell Differentiation; Cells, Cultured; Connective Tissue; Fibroblasts; Free Radical Scavengers; Imidazoles; JNK Mitogen-Activated Protein Kinases; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oligodeoxyribonucleotides, Antisense; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2006 |
Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells.
Topics: Androstadienes; Angiotensin II; Anthracenes; Cells, Cultured; Chromones; Endothelium, Vascular; Enzyme Activation; Focal Adhesion Kinase 1; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Morpholines; Oligonucleotides, Antisense; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Umbilical Veins; Wortmannin | 2009 |
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
Topics: Angiotensin II; Animals; Anthracenes; Carrier Proteins; Cell Division; Cells, Cultured; Disease Models, Animal; Fatty Liver; Fibroblasts; Hepatic Stellate Cells; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Mitogen-Activated Protein Kinase 9; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Transforming Growth Factor beta | 2010 |
SP600125, an inhibitor of c-Jun NH2-terminal kinase, blocks expression of angiotensin II-induced monocyte chemoattractant protein-1 in human mesangial cells.
Topics: Angiotensin II; Anthracenes; Cells, Cultured; Chemokine CCL2; Fibronectins; Half-Life; Humans; JNK Mitogen-Activated Protein Kinases; Mesangial Cells; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Transforming Growth Factor beta | 2010 |
Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes.
Topics: Angiotensin II; Anthracenes; Butadienes; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Imidazoles; MicroRNAs; Myocytes, Cardiac; Nitriles; Pyridines; Receptor, Angiotensin, Type 1; Signal Transduction | 2011 |
Monocyte chemoattractant protein-1 mediates angiotensin II-induced vascular smooth muscle cell proliferation via SAPK/JNK and ERK1/2.
Topics: Angiotensin II; Animals; Anthracenes; Aorta, Thoracic; Benzoxazines; Butadienes; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitriles; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, CCR2 | 2012 |
Angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ₂ in macrophages.
Topics: Acrylates; Angiotensin II; Animals; Anthracenes; Cell Line; Cell Movement; Cell Proliferation; Cytokines; Early Growth Response Protein 1; Flavonoids; Gene Expression Regulation; Imidazoles; Macrophages; Male; MAP Kinase Signaling System; Mice; Prostaglandin D2; Thiophenes; Up-Regulation | 2015 |
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |
A novel role of angiotensin II in epidermal cell lineage determination: Angiotensin II promotes the differentiation of mesenchymal stem cells into keratinocytes through the p38 MAPK, JNK and JAK2 signalling pathways.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Anthracenes; Bone Marrow Cells; Cell Differentiation; Cell Lineage; Cell Movement; Imidazoles; Janus Kinase 2; Janus Kinases; Keratinocytes; Losartan; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tyrphostins | 2019 |
Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells.
Topics: Angiotensin II; Anthracenes; Cell Movement; Cells, Cultured; Coronary Vessels; Cytokines; Endothelial Cells; Glucose; Humans; Hyperbaric Oxygenation; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; JNK Mitogen-Activated Protein Kinases; Losartan; Neovascularization, Pathologic; Nicotinamide Phosphoribosyltransferase; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Signal Transduction | 2020 |